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Abstract 
The islet cell antigen ICA69 is an autoimmune target in most patients with insulin-dependent diabetes. Understanding its 
role in diabetic autoimmunity would be facilitated by an animal model. We therefore cloned mouse ICA69. The different 
splice variants now identified conserve Tep69, the single T cell epitope recognized by patient T cells. We show that 
diabetes-prone NOD mice had Tep69-specific, autoreactive T cell repertoires and thus provide a relevant model for the 
study of ICA69's role in diabetic autoimmunity. © 1997 Elsevier Science B.V. All rights reseved. 
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Autoimmune (Type I or insulin-dependent) dia- 
betes (IDD) reflects the chronic destruction of insulin 
producing /3-cells in the islets of Langerhans [1]. 
Autoimmunity in IDD is triggered by environmental 
factor(s) in genetically susceptible hosts, with the 
main susceptibility locus mapped to MHC class II 
(DQB1, IA g7 in diabetes-prone humans and mice, 
respectively) [1]. The islet cell antigen ICA69 is a 
recently discovered, major target antigen of diabetic 
autoimmunity [2,3]. Over 80% of children with newly 
diagnosed IDD generate autoantibodies or self-reac- 
tive T cells to the molecule [4], and these T cells 
recognize a single epitope, Tep69 [5]. Interest in 
ICA69 derives from the fact that the Tep69 epitope 
* Corresponding author. Fax: +l 416 8136255; E-mail: 
hmdosch @sickkids.on.ca 
was shown to have structural homology and immuno- 
logical cross-reactivity with the ABBOS epitope in 
bovine serum albumin (BSA) [6]. BSA is a con- 
stituent of cow milk, which in turn has been identi- 
fied as an environmental risk factor when encoun- 
tered (usually in infant formula) by susceptible in- 
fants less than three months of age [7,1,8]. 
We recently reported the tissue ICA69 expression 
patterns which showed peak expression levels in 
/3-cells, with considerable gene expression as well in 
brain and testes, where it maps to the trans-Golgi 
region of cells constituting blood-brain and testes- 
blood barrier respectively [9]. To determine if obser- 
vations in patients could be transferred to an experi- 
mental animal model of diabetes (non-obese diabetic, 
NOD, mice), we decided to first characterize murine 
ICA69. A cDNA library was constructed from NOD 
mouse brain with the Uni-ZAP XR cloning vector kit 
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(Stratagene, La Jolla, CA) and 8 × 105 recombinant 
phage were screened with a 320 bp ICA69 cDNA 
fragment from the 5' untranslated (127 bp) and the 
first two coding exons of human ICA69 [3]. Positive 
clones were plaque-purified, inserts were in vivo 
excised and circularized in XLl-blue E. coli with 
R408 helper phage. In addition, a near full length 
coding fragment was PCR amplified from RNA of 
purified (non-diabetes prone) BALB/c  mouse islets 
and cloned. 
Two cDNA sequence patterns were found for the 
murine coding region, one similar to the predominant 
human isoform (c~-transcripts [10]) and one shorter, 
suggesting the possible presence of a new ICA69 
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Fig. 1. A: Comparison of deduced amino acid sequences of mouse and human ICAp69 clones, The translation start sites are lined up, 
positions and is•form classification are shown on the sides. The notation is as follows; - ,  amino acid identity; *, amino acid deletion; 
small letter, silent nucleotide change; capital letter, amino acid change; O, conservative amino acid change. There are three regions of 
sequence homology between ICAp69 and BSA, indicated by black horizontal bars, with the most N-terminal of these homology regions 
called Tep69. The sequence of the synthetic Tep69 peptide is identified with a narrow black bar. A 21 amino acid deletion in mouse brain 
clone mB2A, arising from alternative splicing of exon 1 l, is highlighted (shaded bar). B: Conservational domains of ICAp69: Protein 
sequence divergence human ¢* mouse: A = 25%, B = 0.4%, C = 33%, D = 0%. 
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isoform. Fig. 1A provides a comparison between the 
deduced ICA69 amino acid sequences of mouse 
cDNA clones (roB9 (U26459), mB10 (U26461), 
mB2A (U26460), GenBank Accession codes in 
brackets), the PCR-generated normal mouse islet 
clone, mI2C (U34595) and a previously reported 
human islet cell cDNA clone [3]. No sequence differ- 
ences in ICA69 coding regions were observed be- 
tween BALB/c  and NOD mice. 
Mouse and human ICA69 show remarkable se- 
quence homology. Four domains can be distinguished 
on the basis of protein sequence conservation (Fig. 
1B). After a small (16 residues) N-terminal region 
with 25% divergence between man and mouse (Do- 
main A), there is a large (266 aa) region with only a 
single amino acid change (C ~ Y, 99.6% identity, 
Domain B). This is followed by a stretch of 140 
residues showing 33% amino acid sequence diver- 
gence from the human molecule and 47% base 
changes at the cDNA level (Domain C). The 62 
residue C-terminal region is characterized by 100% 
identity with the human ICA69 sequence (Domain 
D). In both the conserved omains B and D, the 
presence of 256 all silent base changes suggests 
considerable evolutionary pressure to rigidly maintain 
the primary protein structure in these regions of the 
molecule. It is conceivable that these conservational 
sectors represent distinct functional domains in the 
ICA69 protein. 
With the absence of transmembrane r gions or 
characterized structural or enzymatic sequence mo- 
tifs, the primary sequence of murine ICA69 provides 
no obvious clues to the molecule's function. ICA69 
does not show significant sequence homology to any 
other gene currently listed, except for three small 
regions of homology with BSA (black bars, Fig. 1A). 
As shown in Fig. 1A, the Tep69 sequence (aa 36-47) 
is identical in all human and rodent ICA69 clones 
now available. The second BSA homology region (aa 
105-113) is also fully conserved in murine ICA69, 
while there is one amino acid deleted in the third, 
most C-terminal BSA homology region located in 
domain C (aa 256-261). Synthetic peptides were 
generated for functional studies, overlapping with 
each of these homology regions in BSA and ICA69 
(see below). 
Three splice variants of human ICA69 have been 
identified, each removing one or more complete x- 
, .~ ,  I~ t~ I, I, I, 1,18 t, 1 ,0u , , I ,3 l , ,~  3. 
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Fig. 2. Top: Scheme of ICAp69-a (1437 nucleotides, 13 exons) 
and ICAp69-6 transcripts (1376 nucleotides, 12 exons), with 
position of primers (PI, P2) used for expression analysis by RT 
PCR (bottom). The alternatively spliced exon 11 is shown in 
black with expected amplicon sizes. * : position of the conserved 
Tep69 region. 
ons from the full coding region (a-, /3-, -/-transcripts) 
[10]. Two murine ICA69 isoforms are identified here. 
The clone B2A lacks 63 nucleotides in domain C, 
corresponding to an in-frame splice removal of the 
complete genomic coding exon 11. Clones mI2C, 
roB9 and roB10 are equivalent to human ICA69-a 
transcripts which predominate in human tissue and 
remove exon 4 from the coding region. Clone B2A 
represents a new (ICA69-6) transcript (Fig. 2, top) 
which removes exons 4 and 11. 
To analyze the expression of mouse ICA69-a and 
-6 by RT-PCR, cDNAs from various mouse tissues 
was reverse transcribed (MMLV-RT, Gibco BRL, 
Mississauga, Ont.) and PCR amplified with primers 
p69-803 (sense) 5'-GCTTACAAGACCCCATGAAG 
and p69-1120 (antisense) 5'-TCAACAGCAAGAG- 
GTCATCC located on coding exons 9 and 12 of the 
mouse ICA69 gene, respectively, and covering a 
genomic region of over 20 kb [10]. PCR products 
were size-separated, blotted and hybridized with a 
[32P]-end-labelled internal ICA69 oligonucleotide 
probe (p69-1044, 5'-CGAGGAAGCGTGCCTGGG), 
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located on exon 12. To characterize splice junctions, 
PCR products were purified and sequenced. 
Both transcripts were detectable as distinct double 
bands in brain, testis and the NOD mouse-derived 
NIT beta cell line, conforming with results of previ- 
ous gene expression studies [9]. PCR products were 
eluted, purified and sequenced (Fig. 2, bottom). In 
the shorter ICA69-6 isoform, exon 10 is spliced 
in-frame to exon 12. In contrast, in the 317 bp PCR 
product amplified from the longer ICA69-o~ tran- 
script, exon 10 sequence is spliced in-frame to exon 
11, which, in turn is spliced in-frame to exon 12 (not 
shown). 
To examine the expression of ICA69 isoforms at 
the protein level, we analyzed mouse tissue ho- 
mogenates by Western blotting. In brain, testis, pan- 
creas and adrenals, ICA69 immunoreactivity is visi- 
ble as a double band in the 69 kDa range (Fig. 2 
insert). Although exon-specific antibodies were not 
available, the detection of two ICA69 immune reac- 
tive bands with only subtle size differences i  com- 
patible with the expression of two murine ICA69 
protein isoforms in vivo. 
Conservation of the BSA homology regions be- 
tween human and mouse ICA69 now allowed us to 
ask if these sequences are immunogenic and in par- 
ticular if these regions in ICA69 are recognized by 
autoreactive T cell repertoires in diabetes-prone NOD 
M r 
200-- 
97.4-- 
46 1 . 
30-- 
Fig. 3. Western blot analysis murine ICAp69. Protein extracts (5 
/zg/lane) from various mouse tissues were separated by SDS- 
PAGE, electroblotted and probed with polyclonal rabbit anti- 
ICAp69. 
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Fig. 4. NOD mice have self-reactive T cell repertoires that 
recognize the 'human' Tep69 epitope. Six young-adult NOD 
mice were immunized with BSA (50 /zg s.c. in complete adju- 
vant) and regional lymph node cells were obtained 8 days later, 
for culture with the recall antigens indicated. Proliferative re- 
sponses were measured 1 week later by [3H]thymidine incorpora- 
tion. Results are expressed as stimulation i dices (SI: cpm stimu- 
lated/unstimulated cultures). Variations were within _+ 10%. 
Peptide sequences (numbers denote aa position): ABBOS (BSA- 
148) EFKADEKKFWGKYL; Tep69 (ICA69-36) AFIKAT- 
GKKEDE; ICA69-202 KNFDKLKMDVCQ; BSA-394 TSVFD- 
KLKHLVD; ICA69-349 SEEGACKGPVAG; BSA-193 ED- 
KGACLLPKIE. 
mice (Fig. 3). Six-week-old NOD/Lt  (H-2 g7) mice 
(Jackson Laboratories, Bar Harbor, ME) were used in 
three separate xperiments. Each received a single 
s.c. immunization with 50 ~g of one of three pep- 
tides derived from the BSA or the ICA69 homology 
regions (Fig. 4). An ovalbumin peptide (OVA 152-165) 
is immunogenic n NOD mice (Karges et al., unpub- 
lished observation) and served as control. All pep- 
tides were HPLC purified (purity > 99%) and se- 
quence confirmed (Peptide Facility, McMaster Uni- 
versity, Hamilton, Ont.). After 7-9 days, draining 
lymphnodes were collected, and cells (2 x 105/well) 
were incubated for 5 days in serum-free HGM-af 
Medium TM (PromoCell, Heidelberg, Germany) in the 
presence of 0.1-10 /xg of peptide antigen. Prolifera- 
tive responses were measured by incorporation of 
[3H]thymidine as described [5]. Triplicate cultures of 
pooled lymph node cells from 3-6 mice were ana- 
lyzed and results are expressed as mean stimulation 
index (SI, [cpm test antigen/cpm edium control]). 
As shown in Fig. 3, NOD T cells readily re- 
sponded to immunization with ABBOS, Tep69 and 
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the OVA control peptide. Interestingly, and similar to 
T cell repertoires in diabetic children, T cells from 
ABBOS immunized mice recognized Tep69 and vice 
versa, demonstrating the crossreactivity of these epi- 
topes for diabetes-prone NOD mice. Cross-reactivity 
is not a generalized property of possibly promiscuous 
antigen recognition in these animals, as the OVA 
control peptide generated and recalled only specific 
responses. The role of the remaining two homology 
regions is less certain. Weak responses were observed 
with BSA 135 and essentially none to its ICA69 homo- 
logue, nor to the peptides from the third homology 
region (see Fig. 4) in either BSA or ICA69. Similar 
observations were made in hyperimmunized mice 
(data not shown), consistent with the possibility that 
these 'negative' peptides are not bound well by histo- 
compatibility molecules of NOD antigen presenting 
cells. 
These observations establish the presence of 
Tep69-specific, autoreactive T cell repertoires inNOD 
mice that can be recruited by single immunization. 
The extension of similarities between diabetic hu- 
mans and NOD mice to two diabetes-associated envi- 
ronmental and self-epitopes respectively provides a 
structural basis for the study of the role of these 
protein fragments in diabetic autoimmunity. 
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